Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now : Commentary to: 10.1007/s00415-010-5844-5 "One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients" by S. Malucchi et al

J Neurol. 2011 May;258(5):904-7. doi: 10.1007/s00415-011-5941-0.

Authors

Til Menge¹, Hans-Peter Hartung, Bernd C Kieseier

Affiliation

¹ Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

PMID: 21340521
DOI: 10.1007/s00415-011-5941-0

No abstract available

Publication types

Comment
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Neutralizing / blood*
Humans
Immunologic Factors / immunology
Immunologic Factors / therapeutic use*
Interferon-beta / immunology
Interferon-beta / therapeutic use*
Multiple Sclerosis / blood*
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / immunology

Substances

Antibodies, Neutralizing
Immunologic Factors
Interferon-beta